GlassScriptPhysician profile
Huan Pham
NPI 1982227419
$762.77
in general payments reported to CMS, 2019-2025
12 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $135 · 2024: $364 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $264.81 | 2023-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $128.10 | 2024 | Qelbree |
| Pfizer INC. | $75.26 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $62.01 | 2023-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Sanofi Pasteur INC. | $58.97 | 2023-2024 | |
| Tris Pharma INC | $58.81 | 2024-2025 | Dyanavel Xr, Onyda Xr |
| Kaleo, INC. | $39.81 | 2023 | Auvi-Q |
| Glaxosmithkline, LLC. | $17.16 | 2024 | Bexsero |
| Galderma Laboratories, L.P. | $15.25 | 2023 | |
| Abbott Laboratories | $14.57 | 2025 | Id Now Instrument |
| Astrazeneca Pharmaceuticals LP | $14.06 | 2024 | Flumist Quadrivalent |
| Vertical Pharmaceuticals, LLC | $13.96 | 2025 | Relexxii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huan Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.